PPLPHARMA - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 3.3

📊 Swing Trade Analysis: PPL Pharma Ltd (PPLPHARMA)

PPL Pharma offers a moderate swing trade opportunity, with a technically stable setup but weak institutional sentiment and declining earnings. It may suit short-term traders looking for a bounce, but caution is advised due to valuation and volume concerns.

✅ Strengths

Technical Positioning

Current price ₹203 is near DMA50 (₹199) and DMA200 (₹205), suggesting a consolidation zone with potential support.

MACD: 2.31 → Mild bullish crossover.

RSI: 59.0 → Neutral zone, with room to rise.

Valuation & Stability

P/E: 37.6 vs Industry PE: 33.4 → Slightly overvalued but within range.

PEG Ratio: 1.69 → Acceptable for moderate growth.

Debt-to-Equity: 0.17 → Financially stable.

Profit Recovery

PAT Qtr: ₹113 Cr. vs ₹277 Cr. → Despite the drop, Qtr Profit Var shows a 32.7% rebound.

⚠️ Weaknesses

Institutional Sentiment

FII Holding ↓ 0.63% and DII Holding ↓ 0.53% → Reduced confidence from major investors.

Volume Drop

Current volume (18.9L) < 1-week average (31.0L) → Declining interest.

Low Dividend Yield: 0.07% → Minimal passive income.

ROCE: 12.4% & ROE: 9.74% → Moderate capital efficiency.

EPS: ₹5.42 → Modest earnings for current price.

🎯 Optimal Entry Price

Buy Zone: ₹195–₹200

Near DMA50 and recent support, offering a safer entry with limited downside.

🚪 Exit Strategy (If Holding)

Target Exit: ₹220–₹230

Based on recent resistance and swing potential.

Stop Loss: ₹190

Below DMA50 to protect against reversal.

This setup suits short-term swing traders who can monitor momentum and exit on strength. Let me know if you'd like help tracking MACD or RSI signals for timing your entry.

Edit in a page